Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
CNY 32.71
(-0.58%)
CNY 32.71
(-0.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 655.97 Million CNY | -24.11% |
| 2022 | 727.43 Million CNY | 24.09% |
| 2021 | 586.19 Million CNY | 68.1% |
| 2020 | 348.72 Million CNY | -58.78% |
| 2019 | 846.08 Million CNY | -50.81% |
| 2018 | 1.71 Billion CNY | 0.31% |
| 2017 | 1.71 Billion CNY | 5.14% |
| 2016 | 1.63 Billion CNY | 10.31% |
| 2015 | 1.47 Billion CNY | 22.47% |
| 2014 | 1.2 Billion CNY | 24.74% |
| 2013 | 967.76 Million CNY | 32.61% |
| 2012 | 729.79 Million CNY | 56.35% |
| 2011 | 466.77 Million CNY | 13.1% |
| 2010 | 412.72 Million CNY | 67.98% |
| 2009 | 245.7 Million CNY | 98.91% |
| 2008 | 123.52 Million CNY | 62.21% |
| 2007 | 76.15 Million CNY | 103.99% |
| 2006 | 37.33 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 179.82 Million CNY | 37.75% |
| 2024 Q2 | 130.54 Million CNY | -43.99% |
| 2024 Q1 | 233.08 Million CNY | 130.4% |
| 2023 Q4 | 101.16 Million CNY | -37.59% |
| 2023 Q2 | 150.56 Million CNY | -38.14% |
| 2023 Q1 | 243.4 Million CNY | 138.09% |
| 2023 Q3 | 162.1 Million CNY | 7.66% |
| 2023 FY | 552.03 Million CNY | -24.11% |
| 2022 Q1 | 273.95 Million CNY | 111.12% |
| 2022 Q4 | 102.23 Million CNY | -55.47% |
| 2022 Q3 | 229.57 Million CNY | 88.69% |
| 2022 FY | 727.43 Million CNY | 24.09% |
| 2022 Q2 | 121.66 Million CNY | -55.59% |
| 2021 Q2 | 98.09 Million CNY | -48.58% |
| 2021 Q1 | 190.77 Million CNY | 176.33% |
| 2021 Q3 | 167.55 Million CNY | 70.81% |
| 2021 Q4 | 129.76 Million CNY | -22.56% |
| 2021 FY | 586.19 Million CNY | 68.1% |
| 2020 Q3 | 95.46 Million CNY | 84.03% |
| 2020 Q4 | -249.92 Million CNY | -361.81% |
| 2020 FY | 348.72 Million CNY | -58.78% |
| 2020 Q1 | 181.8 Million CNY | 17896.94% |
| 2020 Q2 | 51.87 Million CNY | -71.47% |
| 2019 Q2 | 343.44 Million CNY | -12.15% |
| 2019 FY | 846.08 Million CNY | -50.81% |
| 2019 Q1 | 390.95 Million CNY | 7.85% |
| 2019 Q3 | 112.7 Million CNY | -67.18% |
| 2019 Q4 | -1.02 Million CNY | -100.91% |
| 2018 Q2 | 442.19 Million CNY | -10.66% |
| 2018 Q4 | 362.51 Million CNY | -13.75% |
| 2018 FY | 1.71 Billion CNY | 0.31% |
| 2018 Q1 | 494.94 Million CNY | 12.38% |
| 2018 Q3 | 420.3 Million CNY | -4.95% |
| 2017 Q3 | 426.99 Million CNY | 5.44% |
| 2017 Q2 | 404.95 Million CNY | -8.43% |
| 2017 FY | 1.71 Billion CNY | 5.14% |
| 2017 Q1 | 442.24 Million CNY | 6.06% |
| 2017 Q4 | 440.42 Million CNY | 3.15% |
| 2016 Q2 | 394.1 Million CNY | -5.41% |
| 2016 FY | 1.63 Billion CNY | 10.31% |
| 2016 Q4 | 416.99 Million CNY | 3.45% |
| 2016 Q1 | 416.65 Million CNY | 6.92% |
| 2016 Q3 | 403.1 Million CNY | 2.28% |
| 2015 Q2 | 357.45 Million CNY | -3.29% |
| 2015 FY | 1.47 Billion CNY | 22.47% |
| 2015 Q4 | 389.68 Million CNY | 7.73% |
| 2015 Q3 | 361.72 Million CNY | 1.2% |
| 2015 Q1 | 369.61 Million CNY | 9.45% |
| 2014 FY | 1.2 Billion CNY | 24.74% |
| 2014 Q4 | 337.7 Million CNY | 14.52% |
| 2014 Q1 | 297.88 Million CNY | 12.47% |
| 2014 Q3 | 294.87 Million CNY | 6.56% |
| 2014 Q2 | 276.71 Million CNY | -7.11% |
| 2013 Q2 | 226.21 Million CNY | -4.66% |
| 2013 FY | 967.76 Million CNY | 32.61% |
| 2013 Q4 | 264.86 Million CNY | 10.63% |
| 2013 Q3 | 239.4 Million CNY | 5.83% |
| 2013 Q1 | 237.27 Million CNY | 5.6% |
| 2012 Q1 | 146.06 Million CNY | 8.3% |
| 2012 FY | 729.79 Million CNY | 56.35% |
| 2012 Q2 | 147.96 Million CNY | 1.3% |
| 2012 Q3 | 211.06 Million CNY | 42.65% |
| 2012 Q4 | 224.69 Million CNY | 6.46% |
| 2011 Q2 | 105.26 Million CNY | -14.56% |
| 2011 Q1 | 123.2 Million CNY | 8.74% |
| 2011 FY | 466.77 Million CNY | 13.1% |
| 2011 Q4 | 134.87 Million CNY | 30.41% |
| 2011 Q3 | 103.42 Million CNY | -1.75% |
| 2010 Q1 | 101.98 Million CNY | 16.99% |
| 2010 Q2 | 107.12 Million CNY | 5.04% |
| 2010 Q3 | 90.31 Million CNY | -15.69% |
| 2010 Q4 | 113.3 Million CNY | 25.46% |
| 2010 FY | 412.72 Million CNY | 67.98% |
| 2009 Q1 | 43.25 Million CNY | 52.97% |
| 2009 Q2 | 58.49 Million CNY | 35.21% |
| 2009 Q3 | 56.77 Million CNY | -2.93% |
| 2009 FY | 245.7 Million CNY | 98.91% |
| 2009 Q4 | 87.17 Million CNY | 53.53% |
| 2008 Q3 | 37.82 Million CNY | 0.0% |
| 2008 FY | 123.52 Million CNY | 62.21% |
| 2008 Q4 | 28.28 Million CNY | -25.23% |
| 2007 FY | 76.15 Million CNY | 103.99% |
| 2006 FY | 37.33 Million CNY | 0.0% |